Medicago inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing vaccines and therapeutic proteins to address infectious diseases across the world. The Company has two product vaccines: Pandemic flu vaccine and Seasonal flu vaccine. Pandemic flu vaccine, developed as H5N1 vaccine using its manufacturing technologies that use plants as a bioreactor. Seasonal flu vaccine, developed and manufactured vaccine for contagious respiratory illness that can cause mild to severe illness, and at times can lead to death. The Company uses Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The Company has developed three technologies for the development of vaccines: its plant-based Proficia technology, Virus-Like Particles, and the VLPExpress platform.